Overview


According to FutureWise analysis the market for Acitretin in 2023 is US$ 32.9 million, and is expected to reach US$ 47.6 million by 2031 at a CAGR of 4.70%.

Acitretin, an oral retinoid derived from vitamin A, is employed in treating severe psoriasis, typically at a daily dosage of 0.25–1 mg per kg body weight, preferably taken after a meal rich in fat to facilitate absorption. It is available in capsule form, with 10 mg and 25 mg options. Acitretin exhibits notable efficacy in specific psoriasis variants like pustular psoriasis, erythrodermic psoriasis, and psoriasis affecting the hands and feet, although it is not practical for psoriatic arthritis. Additionally, it finds occasional use in addressing various other dermatological conditions. However, it is imperative to emphasize that acitretin is strictly contraindicated during pregnancy due to its potential to harm unborn children and cause congenital disabilities. Strict birth control measures are essential during treatment and three years’ post-cessation of acitretin. This medication is rarely prescribed to females of child-bearing potential; if so, they must undergo regular blood pregnancy tests. Furthermore, individuals on acitretin should refrain from donating blood throughout the treatment period and for three years afterward. Notably, acitretin does not impact male sexual function or offspring, allowing males of all ages to take it safely.

Nevertheless, potential side effects may limit dosage, including dry lips, nostril dryness leading to crusting and bleeding, dry eyes, and reddened skin. Moreover, high-dose retinoid therapy can lead to mood changes, including irritability, aggression, and depression. Understanding and managing these potential effects is crucial for individuals undergoing acitretin treatment and for healthcare professionals overseeing their care.

FutureWise Market Research has published a report that provides an insightful analysis of Acitretin Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Acitretin Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • AvKARE LLC
  • Biophore India Pharmaceuticals Ltd
  • Chongqing Huapont Pharmaceutical Co. Ltd
  • Glopec International Plc
  • Hangzhou Jinlan Pharmaceutical technology Development Co. Ltd
  • Merck KGaA
  • Prasco Laboratories
  • SGPharma Pvt Ltd
  • Sionc Pharmaceuticals Pvt Ltd
  • Stiefel Laboratories Inc
  • Sun Pharma Industries
  • Teva Pharmaceuticals Inc

(Note: The list of the major players will be updated with the latest market scenario and trends)

An increase in the prevalence of psoriasis and other skin disorders in which the use of od acitretin is primarily done as the treatment drives the market growth. Raising awareness among both individuals and healthcare professionals regarding psoriasis and improved diagnostic techniques lead to earlier and more frequent diagnoses, thereby increasing the demand for treatments like acitretin. Advancements in the technologies and interventions through the ongoing research and development to improve the drug formulations and delivery mechanisms for acitretin may enhance patient compliance and efficacy, thus driving the market. The geriatric population is growing, and with this, the aged population is more prone to skin disorders, including psoriasis; hence, the demand for this is increasing, and so is the market growth. Improvement in the healthcare infrastructure and expansion in healthcare expenditures, especially in developing nations, contribute to better accessibility to specialized treatments and propelling market growth.

However, like other drugs, acitretin also exhibits potential side effects if taken in excess or misused, which can lead to toxicity, teratogenicity (in which it can harm the fetus during the pregnancy), and mucocutaneous effects; this can limit the use of such drugs. Multiple alternatives to these medicines are available for skin disease, including biologic therapies and other systemic drug treatments, which may pose a challenge to the market of acitretin.

By Product Type

  • Branded
  • Generics
  • Others

By Dose Strength

  • 10 mg
  • 25mg
  • 50mg

By Application

  • Psoriasis
  • Solid Organ Transplant
  • Darier Disease
  • Pityriasis Rubra Pilaris

By Distribution Channel

  • Dermatology Clinics
  • Specilaty Clinic
  • Hospitals
  • Ambulatory Surgical centre
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America is expected to hold the largest market share due to a strong base of healthcare, high expenditure on healthcare, expansion of healthcare infrastructure, strong market players, increase in the prevalence of the skin disorders and a rise in research and development activities in this field. Asia-Pacific is expected to show significant growth due to the increased medical tourism, healthcare sector expansion, research activities, and large population pool, which is driving the market growth in this region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Acitretin Market By Product Type, By Dose Strength, By Application, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Acitretin Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Acitretin Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Acitretin Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Acitretin Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Branded
        2. Generics
        3. Others

  • 8.   Acitretin Market, By Dose Strength Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. 10 mg
        2. 25mg
        3. 50mg

  • 9.   Acitretin Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Psoriasis
        2. Solid Organ Transplant
        3. Darier Disease
        4. Pityriasis Rubra Pilaris

  • 10.   Acitretin Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Dermatology Clinics
        2. Specilaty Clinic
        3. Hospitals
        4. Ambulatory Surgical centre
        5. Others

  • 11.   North America Acitretin Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Acitretin Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Acitretin Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Acitretin Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. AvKARE LLC
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Biophore India Pharmaceuticals Ltd
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Chongqing Huapont Pharmaceutical Co. Ltd
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Glopec International Plc
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Hangzhou Jinlan Pharmaceutical technology Development Co. Ltd
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Merck KGaA
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Prasco Laboratories
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. SGPharma Pvt Ltd
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Sionc Pharmaceuticals Pvt Ltd
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Stiefel Laboratories Inc
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Sun Pharma Industries
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Teva Pharmaceuticals Inc
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients